IRIS
RICCARDI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.890
EU - Europa 1.570
NA - Nord America 1.267
SA - Sud America 326
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.230
SG - Singapore 940
RU - Federazione Russa 735
IT - Italia 492
CN - Cina 455
BR - Brasile 274
VN - Vietnam 195
HK - Hong Kong 161
DE - Germania 93
NL - Olanda 39
GB - Regno Unito 34
IN - India 31
FR - Francia 29
FI - Finlandia 28
AR - Argentina 26
KR - Corea 26
CI - Costa d'Avorio 24
ES - Italia 24
CA - Canada 21
IE - Irlanda 17
BD - Bangladesh 15
BE - Belgio 15
JP - Giappone 15
SE - Svezia 15
PL - Polonia 11
AT - Austria 10
MA - Marocco 10
ID - Indonesia 9
ZA - Sudafrica 9
EC - Ecuador 8
MX - Messico 8
CO - Colombia 7
GR - Grecia 5
IQ - Iraq 5
PK - Pakistan 5
UA - Ucraina 5
LT - Lituania 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
MY - Malesia 3
NP - Nepal 3
UY - Uruguay 3
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
PY - Paraguay 2
RO - Romania 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
UZ - Uzbekistan 2
AL - Albania 1
BO - Bolivia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 5.111
Salva come PNG Salva come JPEG
Città #
Singapore 444
Moscow 196
Chandler 186
Hong Kong 159
Beijing 148
Hefei 134
Ashburn 120
Naples 117
Napoli 96
Santa Clara 91
Ho Chi Minh City 59
Dong Ket 40
Los Angeles 37
Millbury 36
Hanoi 32
Munich 29
Amsterdam 25
Lawrence 25
Seoul 25
Des Moines 24
São Paulo 24
Nanjing 23
New York 23
Redondo Beach 23
Rome 23
Buffalo 22
Milan 22
Boston 21
Dallas 15
Nuremberg 15
Madrid 13
Kochi 12
Princeton 12
Houston 11
Turku 11
Wilmington 11
Düsseldorf 10
Rio de Janeiro 10
Belo Horizonte 9
Brussels 9
Seattle 9
Warsaw 9
Casablanca 8
Da Nang 8
Ottawa 8
Redwood City 8
Stockholm 8
Tokyo 8
Vienna 8
Frankfurt am Main 7
Guangzhou 7
Torre del Greco 7
Hải Dương 6
Lappeenranta 6
London 6
Norwalk 6
Salerno 6
Caserta 5
Chennai 5
Chicago 5
Fairfield 5
Helsinki 5
Montreal 5
Woodbridge 5
Atlanta 4
Bexley 4
Biên Hòa 4
Brasília 4
Cinisello Balsamo 4
Curitiba 4
Denver 4
Dhaka 4
Fisciano 4
Forlì 4
Goiânia 4
Guarulhos 4
Guayaquil 4
Jiaxing 4
Manchester 4
Nanchang 4
Orem 4
Osasco 4
Pune 4
Ribeirão Preto 4
Salt Lake City 4
Salvador 4
Toronto 4
Zhengzhou 4
Bologna 3
Brooklyn 3
Campo Grande 3
Cava de' Tirreni 3
Changsha 3
Esneux 3
Fortaleza 3
Foshan 3
Gifu 3
Johannesburg 3
Kronberg 3
Las Vegas 3
Totale 2.634
Salva come PNG Salva come JPEG
Nome #
Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems 146
BENZODIFURAN DERIVATIVES AS POTENTIAL ANTIPROLIFERATIVE AGENTS: POSSIBLE CORRELATION BETWEEN THE BIOACTIVITY AND THEIR AGGREGATION PROPERTIES 145
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. 141
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 140
"dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents 136
Ru(III) complexes for anticancer therapy: the importance of being nucleolipidic 129
On the pH-Modulated Ru-Based Prodrug Activation Mechanism 123
Stability is not everything the case of the cyclization of the thrombin binding aptamer 122
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics 116
Anticancer activity of a cationic Ru-based nanosystem in a human xenograft model of breast cancer 116
Fighting the Huntington’s Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies 111
Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better! 110
Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one! 110
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 110
G-quadruplex-based aptamers against protein targets in therapy and diagnostics 110
Nucleolipidic-based liposomes effectively deliver a Ru(III) complex across cell membranes to nuclei promoting in concert apoptosis and autophagy in human models of breast cancer 110
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound 110
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 107
Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics 106
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 104
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers 104
A terminal functionalization strategy reveals unusual binding abilities of anti-thrombin anticoagulant aptamers 103
Disentangling the Structure-Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs 101
Preclinical validation of an original Ru(III)-based nanosystem in human models of breast cancer 100
Affinity chromatography-based assays for the screening of potential ligands selective for G-quadruplex structures 100
Fluorescent Thrombin Binding Aptamer-Tagged Nanoparticles for an Efficient and Reversible Control of Thrombin Activity 99
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 98
Exploring the Binding of Natural Compounds to Cancer-Related G-Quadruplex Structures: From 9,10-Dihydrophenanthrenes to Their Dimeric and Glucoside Derivatives 96
Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures 96
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 96
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity 95
Fine-tuning the properties of the thrombin binding aptamer through cyclization: Effect of the 5′-3′ connecting linker on the aptamer stability and anticoagulant activity 95
G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents 93
Synthesis, antiproliferative activity, and DNA binding studies of nucleoamino acid-containing Pt(II) complexes 91
AS1411-decorated niosomes as effective nanocarriers for Ru(III)-based drugs in anticancer strategies 90
G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects 88
RuIII Complexes for Anticancer Therapy: The Importance of Being Nucleolipidic 87
Selective light-up of dimeric G-quadruplex forming aptamers for efficient VEGF165 detection 86
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(III) complex with superior anticancer bioactivity 85
Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition 83
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 81
Charge-transfer interactions stabilize g-quadruplex-forming thrombin binding aptamers and can improve their anticoagulant activity 77
Synthesis and characterization of multifunctional nanovesicles composed of POPC lipid molecules for nuclear imaging 77
Modular symmetric ligands for selective recognition of cancer-relevant G-quadruplexes 76
Design, synthesis and characterization of cyclic nu172 analogues: A biophysical and biological insight 75
Design, Synthesis, and Characterization of an Amphiphilic Lipoic Acid-Based Ru(III) Complex as a Versatile Tool for the Functionalization of Different Nanosystems 64
Natural compounds from Juncus plants interacting with telomeric and oncogene G-quadruplex structures as potential anticancer agents 63
Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study 62
When annealing is detrimental: The case of HMGB1-targeting G-quadruplex aptamers 60
Metal-Based Complexes in Cancer 60
Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer 55
Probing naphthalene diimide and 3-hydroxypropylphosphate as end-conjugating moieties for improved thrombin binding aptamers: Structural and biological effects 54
Understanding the biological activities of vitamin d in type 1 neurofibromatosis: New insights into disease pathogenesis and therapeutic design 49
Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases 48
Nucleic acid-based aptamers in therapeutics and diagnostics 32
Covalently linked dimers of a G-quadruplex-forming aptamer as HMGB1 inhibitors 23
Totale 5.244
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.597
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 12 4 2 23 16 1 42
2021/2022234 0 0 1 7 5 7 7 10 37 10 66 84
2022/2023471 45 51 8 31 52 51 14 51 68 47 37 16
2023/2024334 11 68 43 27 17 26 24 34 4 0 45 35
2024/20251.657 75 98 14 33 28 105 150 109 83 174 623 165
2025/20262.008 328 346 420 278 557 79 0 0 0 0 0 0
Totale 5.244